98 related articles for article (PubMed ID: 35526384)
1. Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash.
Min F; Fan C; Zeng Y; He N; Zeng T; Qin B; Shi Y
Int Immunopharmacol; 2022 Aug; 109():108804. PubMed ID: 35526384
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
3. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study.
Dastgheib L; Rostami F; Gharesi-Fard B; Asadi-Pooya AA; Namjoo S; Tahmasebi F; Hadibarhaghtalab M
Iran J Med Sci; 2023 Jan; 48(1):70-76. PubMed ID: 36688194
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
Front Immunol; 2021; 12():653710. PubMed ID: 33912179
[TBL] [Abstract][Full Text] [Related]
5. Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese.
Li LJ; Hu FY; Wu XT; An DM; Yan B; Zhou D
Epilepsy Res; 2013 Sep; 106(1-2):296-300. PubMed ID: 23830818
[TBL] [Abstract][Full Text] [Related]
6. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
Neuman MG; Cohen L; Nanau RM; Hwang PA
Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
[TBL] [Abstract][Full Text] [Related]
7. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
8. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhou P; Zhang S; Wang Y; Yang C; Huang J
J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
[TBL] [Abstract][Full Text] [Related]
11. HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
Amstutz U; Ross CJ; Castro-Pastrana LI; Rieder MJ; Shear NH; Hayden MR; Carleton BC;
Clin Pharmacol Ther; 2013 Jul; 94(1):142-9. PubMed ID: 23588310
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
Hung SI; Chung WH; Jee SH; Chen WC; Chang YT; Lee WR; Hu SL; Wu MT; Chen GS; Wong TW; Hsiao PF; Chen WH; Shih HY; Fang WH; Wei CY; Lou YH; Huang YL; Lin JJ; Chen YT
Pharmacogenet Genomics; 2006 Apr; 16(4):297-306. PubMed ID: 16538176
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Drug-Specific CD4
Jaruthamsophon K; Thomson PJ; Hammond S; Zhang E; Alfirevic A; Sukasem C; Naisbitt DJ; Pirmohamed M
Chem Res Toxicol; 2023 May; 36(5):757-768. PubMed ID: 37074725
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
[TBL] [Abstract][Full Text] [Related]
16. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.
Zhang Y; Wang J; Zhao LM; Peng W; Shen GQ; Xue L; Zheng XX; He XJ; Gong CY; Miao LY
Eur J Clin Pharmacol; 2011 Sep; 67(9):885-7. PubMed ID: 21424386
[TBL] [Abstract][Full Text] [Related]
17. Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients.
Then SM; Rani ZZ; Raymond AA; Ratnaningrum S; Jamal R
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):290-3. PubMed ID: 22053601
[TBL] [Abstract][Full Text] [Related]
18. HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions.
Shi YW; Min FL; Zhou D; Qin B; Wang J; Hu FY; Cheung YK; Zhou JH; Hu XS; Zhou JQ; Zhou LM; Zheng ZZ; Pan J; He N; Liu ZS; Hou YQ; Lim KS; Ou YM; Hui-Ping Khor A; Ng CC; Mao BJ; Liu XR; Li BM; Kuan YY; Yi YH; He XL; Deng XY; Su T; Kwan P; Liao WP
Neurology; 2017 Jun; 88(23):2183-2191. PubMed ID: 28476759
[TBL] [Abstract][Full Text] [Related]
19. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.
Alfirevic A; Jorgensen AL; Williamson PR; Chadwick DW; Park BK; Pirmohamed M
Pharmacogenomics; 2006 Sep; 7(6):813-8. PubMed ID: 16981842
[TBL] [Abstract][Full Text] [Related]
20. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome.
Bellón T; Ramírez E; Borobia AM; Lerma V; Moreno-Hidalgo MA; Laosa O; Aramburu JA; González-Herrada C; de Abajo FJ
Pharmacogenomics; 2016 Apr; 17(6):541-5. PubMed ID: 27020614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
